TOBAM - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 64 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
TOBAM ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q2 2020$1,296,000
+45.9%
46,979
-5.5%
0.08%
+18.6%
Q1 2020$888,000
-10.3%
49,727
+25.9%
0.07%
+14.8%
Q4 2019$990,000
+18.4%
39,502
-15.7%
0.06%
+13.0%
Q3 2019$836,000
+14.7%
46,853
+41.5%
0.05%
+31.7%
Q2 2019$729,000
-41.7%
33,121
-19.0%
0.04%
-34.9%
Q1 2019$1,251,000
+122.2%
40,901
+67.7%
0.06%
+133.3%
Q4 2018$563,00024,3850.03%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Zeal Asset Management Ltd 2,339,885$93,421,00021.31%
UG Investment Advisers Ltd. 33,155$1,302,0002.52%
Pinz Capital Management, LP 159,400$6,260,0001.88%
Capital International Sarl 547,743$21,510,0001.86%
Capital International, Inc./CA/ 4,391,684$172,461,0001.54%
AIA Group Ltd 437,118$17,380,0001.20%
York Capital Management Global Advisors, LLC 182,297$7,159,0000.80%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 68,000$2,671,0000.70%
E Fund Management (Hong Kong) Co., Ltd. 18,579$730,0000.46%
M&G INVESTMENT MANAGEMENT LTD 4,512,562$175,990,0000.44%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders